Table 1.
Patient Baseline Characteristicsa
| Characteristics | Standard Care (n = 79) | Palliative Care (n = 81) |
|---|---|---|
| Age, mean (SD), y | 56.9 (14.1) | 57.2 (12.7) |
| Female, No. (%) | 43 (54.4) | 48 (59.3) |
| Diagnosis, No. (%) | ||
| Acute lymphoblastic leukemia | 7 (9.0) | 4 (5.0) |
| Acute myeloid leukemia/myelodysplastic syndrome | 23 (29.5) | 24 (30.0) |
| Myelofibrosis/chronic myeloid leukemia | 7 (9.0) | 8 (10.0) |
| Lymphoma | 26 (33.3) | 18 (22.5) |
| Multiple myeloma | 15 (19.2) | 26 (32.5) |
| Race, No. (%) | ||
| White | 70 (88.6) | 69 (85.2) |
| Other | 9 (11.4) | 12 (14.8) |
| Relationship status, No. (%) | ||
| Married | 55 (69.6) | 63 (77.8) |
| Divorced | 9 (11.4) | 5 (6.2) |
| Single | 10 (12.7) | 10 (12.4) |
| Widowed | 5 (6.3) | 3 (3.7) |
| Education, No. (%) | ||
| High school | 24 (30.4) | 23 (28.4) |
| College | 42 (53.2) | 35 (43.2) |
| Postgraduate | 13 (16.5) | 23 (28.4) |
| Annual income, No. (%), $ | ||
| ≤50 999 | 29 (40.3) | 20 (27.4) |
| 51 000–100 000 | 19 (26.4) | 29 (39.7) |
| >100 000 | 24 (33.3) | 24 (32.9) |
| Missing | 7 (8.9) | 8 (9.9) |
| HCT Comorbidity Index, median (IQR) | 3 (2) | 3 (3) |
| ECOG Performance Status score, No. (%) | ||
| 0 | 28 (35.4) | 27 (33.3) |
| 1 | 49 (62.0) | 54 (66.7) |
| 2 | 2 (2.5) | 0 |
| Transplant type, No. (%) | ||
| Autologous HCT | 39 (49.4) | 41 (50.6) |
| Myeloablative allogeneic HCT | 14 (17.7) | 16 (19.8) |
| Reduced-intensity allogeneic HCT | 26 (32.9) | 24 (29.6) |
| Donor type (allogeneic), No. (%) | ||
| Matched related donor | 11 (27.5) | 11 (27.5) |
| Matched unrelated donor | 23 (57.5) | 22 (55) |
| Haploidentical donor | 4 (10.0) | 7 (17.5) |
| Cord | 2 (5.0) | 0 |
| HCT hospital length of stay, mean (SD), d | 21.7 (5.4) | 21.9 (11.2) |
| FACT-BMT score, mean (SD)a | 107.3 (20.7) | 110.3 (19.1) |
| FACT Fatigue score, mean (SD)b | 36.9 (10.8) | 38.1 (10.3) |
| PHQ-9 score, mean (SD)c | 5.4 (4.7) | 4.8 (4.4) |
| HADS Depression score, mean (SD)d | 4.9 (4.1) | 4.0 (3.2) |
| HADS Anxiety score, mean (SD)d | 5.4 (3.8) | 4.6 (3.6) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; HCT, hematopoietic stem cell transplantation; IQR, interquartile range.
a
The range for the Functional Assessment of Cancer Therapy–Bone Marrow Transplant (FACT-BMT) is 0 to 164.
b
The range for the Functional Assessment of Cancer Therapy Fatigue subscale (FACT Fatigue) is 0 to 52.
c
The range for the Patient Health Questionnaire 9 (PHQ-9) is 0 to 27.
d
The range for the Hospital Anxiety and Depression Scale (HADS) Anxiety and Depression subscales is 0 to 21.